<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our objectives were to evaluate thrombotic complications in patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> fulfilling Sapporo criteria, anticoagulated with an intended INR 2.0-3.0 due to venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In our series standard anticoagulation was safe and efficacious in preventing recurrences in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, with other <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and with <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
</text></document>